Heximar Ointment is formulated for use on body skin and is not recommended for the scalp, where hair may impede proper coverage. Patients with scalp psoriasis should discuss alternative formulations, such as shampoos or solutions, with their clinician.
If the treated area becomes intensely red, swollen, or blistered, stop using the ointment and seek medical attention promptly. The prescriber may suggest a temporary discontinuation or a switch to a different therapy.
Applying the ointment at night is common practice because it allows the medication to remain undisturbed while the skin repairs. Ensure the area is clean and dry before application.
A 15 g tube generally provides enough product for 2-3 weeks of once-daily application, depending on the size and number of lesions treated.
Concurrent use of other topical agents should be coordinated with a healthcare professional. Some creams may interfere with absorption or increase irritation risk.
Yes, Heximar Ointment is a prescription-only medicine (POM) in the United Kingdom and must be obtained through a qualified prescriber.
Standard laboratory tests are not typically influenced by topical calcipotriol. However, if large skin areas are treated, calcium levels might be monitored.
Prolonged use on extensive areas can occasionally cause mild skin lightening or darkening. Report any noticeable changes to a healthcare provider.
Yes, the tube can be carried in hand luggage. Keep it in its original packaging and ensure the cap is securely tightened to prevent leaks.
No specific interactions between calcipotriol and over-the-counter antihistamines have been reported. Nonetheless, disclose all medications to your prescriber.
Heximar Ointment contains calcipotriol as its active ingredient. Calcipotriol is a synthetic analogue of vitamin D that belongs to the skin-care therapeutic class. The product is supplied in a plastic tube and is available in two tube sizes: 15 g and 30 g. In the United Kingdom Heximar Ointment is a prescription-only medicine (POM) regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).
Calcipotriol binds to the vitamin D receptor (VDR) found in skin cells. Activation of this receptor modifies the expression of genes involved in cell growth and differentiation. By normalising keratinocyte proliferation and encouraging the maturation of skin cells, calcipotriol reduces the thick, scaly plaques that are characteristic of psoriasis. The effect typically becomes noticeable after several weeks of consistent use. Oral absorption from topical application is minimal, so systemic exposure is low.
Heximar Ointment is approved in the UK for the topical treatment of plaque psoriasis in adults. The indication covers mild to moderate disease that is limited to body surface areas where an ointment can be applied. It is not intended for use on facial skin, intertriginous areas, or mucous membranes unless specifically directed by a specialist.
Typical patients are adults with chronic plaque psoriasis who have not responded adequately to emollients alone. Calcipotriol may be used as monotherapy or in combination with other topical agents such as corticosteroids, as directed by a clinician.
No robust peer-reviewed evidence currently supports off-label uses of calcipotriol in Heximar Ointment. Consequently, this section is omitted.
If any of these conditions apply, a healthcare professional should evaluate suitability before prescribing Heximar Ointment.
Patients should disclose all medications, supplements, and over-the-counter skin products to their healthcare provider before starting Heximar Ointment.
Routine clinical review is recommended after 4-6 weeks of treatment to assess efficacy and skin tolerance. If large surface areas are being treated, periodic monitoring of serum calcium may be advised by the prescriber.
This article provides educational information about Heximar Ointment and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
